Proteotech, Inc.

Kirkland, WA 98034

SBIR Award Summary

Total Number of Awards 27
Total Value of Awards $13MM
First Award Date 02/15/99
Most Recent Award Date 06/01/14

Key Personnel

Last Name Name Awards Contact
Snow Alan D. Snow 18
Castillo Gerardo M Castillo 8
Garrigues Jacques Garrigues 1

27 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 06/01/14 - 05/31/15

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is characterized by brain amyloid plaques consisting of insoluble beta-amyloid protein (A?), and neurofibrillary tangles (NFTs) containing aggregated tau protein. AD drug discovery efforts have been largely focused on reducing brain A? levels, with much less emphasis on tau-directed s...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/01/13 - 05/31/14

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is characterized by brain amyloid plaques consisting of insoluble beta-amyloid protein (A?), and neurofibrillary tangles (NFTs) containing aggregated tau protein. AD drug discovery efforts have been largely focused on reducing brain A? levels, with much less emphasis on tau-directed s...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 06/15/11 - 05/31/12

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is characterized by brain amyloid plaques consisting of insoluble beta-amyloid (A2) and tau protein containing neurofibrillary tangles (NFTs). AD drug discovery strategies have been largely focused on reducing brain A2 levels, with substantially less emphasis on tau-directed approa...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-280
Budget: 05/01/10 - 10/31/11

DESCRIPTION (provided by applicant): Systemic AA Amyloidosis is characterized by the accumulation of insoluble fibril deposits containing the AA amyloid protein in different organs throughout the body including heart, kidney, liver, spleen, lungs, skin and gastrointestinal tract, whereby such amyloid fibril accumulation leads to pronounced organ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-280
Budget: 05/01/09 - 04/30/10

DESCRIPTION (provided by applicant): Systemic AA Amyloidosis is characterized by the accumulation of insoluble fibril deposits containing the AA amyloid protein in different organs throughout the body including heart, kidney, liver, spleen, lungs, skin and gastrointestinal tract, whereby such amyloid fibril accumulation leads to pronounced organ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 05/15/08 - 04/30/09

DESCRIPTION (provided by applicant): Systemic AA Amyloidosis is characterized by the accumulation of insoluble fibril deposits containing the AA amyloid protein in different organs throughout the body including heart, kidney, liver, spleen, lungs, skin and gastrointestinal tract, whereby such amyloid fibril accumulation leads to pronounced organ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/08 - 12/31/09

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a degenerative brain disorder characterized clinically by progressive loss of memory, cognition, reasoning, and judgment that gradually leads to profound mental deterioration and ultimately death. AD is the leading cause of dementia in the elderly and is characterized by the brain ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/15/07 - 03/31/08

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a degenerative brain disorder characterized clinically by progressive loss of memory, cognition, reasoning, and judgment that gradually leads to profound mental deterioration and ultimately death. AD is the leading cause of dementia in the elderly and is characterized by the brain ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/06 - 03/31/07

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a degenerative brain disorder characterized clinically by progressive loss of memory, cognition, reasoning, and judgment that gradually leads to profound mental deterioration and ultimately death. AD is the leading cause of dementia in the elderly and is characterized by the brain ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/05 - 05/31/06

Alzheimer's disease (AD) is a degenerative brain disorder characterized clinically by progressive loss of memory, cognition, reasoning, judgement and emotional stability that gradually leads to profound mental deterioration and ultimately death. AD is the leading cause of dementia in the elderly, today affecting 4-5 million Americans, which is e...

Load More